Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.
Saved in:
| Title: | Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells. |
|---|---|
| Authors: | Moreb JS; Hematology/Oncology Division, Department of Medicine, University of Florida, 1600 SW Archer Rd, PO Box 100277, Gainesville, FL, 32610, USA. morebsj@medicine.ufl.edu., Ucar-Bilyeu DA; Genetics Department, LSU College of Medicine, New Orleans, LA, USA., Khan A; Hematology/Oncology Division, Department of Medicine, University of Florida, 1600 SW Archer Rd, PO Box 100277, Gainesville, FL, 32610, USA. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2017 Feb; Vol. 79 (2), pp. 295-301. Date of Electronic Publication: 2016 Dec 10. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-016-3213-5 |
